Literature DB >> 16785739

Focal segmental glomerulosclerosis--does treatment work?

C M Stirling1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16785739     DOI： 10.1159/000093994

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN： 1660-2110


× No keyword cloud information.
  4 in total

1.  Collapsing focal segmental glomerulosclerosis: Current concepts.

Authors:  Muhammed Mubarak
Journal:  World J Nephrol       Date:  2012-04-06

2.  Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade?

Authors:  Neveen A Soliman; Magdi Francis; Saskia F Heeringa; Gil Chernin
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

3.  Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS.

Authors:  Lawrence Copelovitch; Marta Guttenberg; Martin R Pollak; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-05-25       Impact factor: 3.714

4.  Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice.

Authors:  Shun-Min Yang; Kuo-Feng Hua; Yu-Chuan Lin; Ann Chen; Jia-Ming Chang; Louis Kuoping Chao; Chen-Lung Ho; Shuk-Man Ka
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.